» Articles » PMID: 35283624

Health Related Quality of Life of Rosacea Patients in China Assessed by Dermatology Life Quality Index and Willingness to Pay

Overview
Date 2022 Mar 14
PMID 35283624
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Rosacea is a chronic inflammatory dermatosis mainly involving facial skin, leading to physical and emotional problems, which greatly affect the quality of life (QoL) of patients. Dermatology Life Quality Index (DLQI) and willingness to pay (WTP) are well-established instruments assessing the health-related quality of life (HRQoL), while very few studies have been focused on this topic about rosacea in China. The present study investigated HRQoL in Chinese rosacea patients.

Patients And Methods: This cross-sectional study was conducted on 973 patients with rosacea. Sociodemographic data, clinical features and DLQI were collected, and WTP was assessed by three standardized items. Multivariable logistic analysis was performed to investigate independent factors influencing QoL.

Results: A total of 921 questionnaires were accomplished by participants. The mean DLQI score was 11.6 (median 11). Patients were willing to pay an average of € 896.2 (median € 368.1) for complete cure. 33.3% would like to pay more than 20% of their monthly income to achieve sustainable control. There were positive correlations between WTP with DLQI ( < 0.05). DLQI could be independently impacted by age (21-30 and 31-40 relative to > 50, OR = 3.242 and 3.617, respectively), the occupational requirement of appearance (high, OR = 4.410), disease duration (< 2 years, OR = 1.582), edema (OR = 1.844) and severity of flushing, burning, stinging and pruritus (severe, OR = 2.003, 1.981, 2.491, 2.249, respectively). There were no significant associations between WTP and most of the clinical factors.

Conclusion: The QoL was greatly impaired and should not be ignored among rosacea patients in China. Patients aged 21-40y, having occupational requirement of appearance, with the disease duration less than 2 years, and suffering severe flushing and related sensitive symptoms were more likely to have severe or very severe limitation of QoL.

Citing Articles

Novel Thermosensitive Hydrogel Encapsulated Carvedilol for the Treatment of Rosacea.

Chen H, Zhang Z, Qi J, Cao C, Lin M, Lyu L ACS Omega. 2025; 10(8):7964-7972.

PMID: 40060832 PMC: 11886671. DOI: 10.1021/acsomega.4c08884.


Exploring the psychodermatologic burden and associated psychiatric manifestations in rosacea: a systemic review.

Sharifi S, Katamanin O, Jafferany M Arch Dermatol Res. 2025; 317(1):427.

PMID: 39954108 DOI: 10.1007/s00403-025-03982-w.


Assessment of Depressive and Anxiety Symptoms and Health-Related Quality of Life in Rosacea Patients: A Case-Control Study.

Seetan K, Gablan M, Alnaimi M, Alhazaimeh D, Younes M, Alnaimi A Dermatol Res Pract. 2024; 2024:5532532.

PMID: 39720781 PMC: 11668539. DOI: 10.1155/drp/5532532.


Health-related Quality of Life of Patients with Rosacea: A Systematic Review and Meta-analysis of Real-world Data.

Chiu C, Tsai J, Huang Y Acta Derm Venereol. 2024; 104:adv40053.

PMID: 38916178 PMC: 11218680. DOI: 10.2340/actadv.v104.40053.


Dietary Antioxidants May Support Cosmetic Treatment in Patients with Rosacea.

Zujko-Kowalska K, Maslowska J, Knas-Dawidziuk M, Hamulka J, Zujko M Antioxidants (Basel). 2024; 13(3).

PMID: 38539914 PMC: 10968324. DOI: 10.3390/antiox13030381.


References
1.
Aksoy B, Altaykan-Hapa A, Egemen D, Karagoz F, Atakan N . The impact of rosacea on quality of life: effects of demographic and clinical characteristics and various treatment modalities. Br J Dermatol. 2010; 163(4):719-25. DOI: 10.1111/j.1365-2133.2010.09894.x. View

2.
Zhang H, Tang K, Wang Y, Fang R, Sun Q . Rosacea Treatment: Review and Update. Dermatol Ther (Heidelb). 2020; 11(1):13-24. PMC: 7858727. DOI: 10.1007/s13555-020-00461-0. View

3.
Wang K, Wang K, Zhang Z . Health-related quality of life and marital quality of vitiligo patients in China. J Eur Acad Dermatol Venereol. 2010; 25(4):429-35. DOI: 10.1111/j.1468-3083.2010.03808.x. View

4.
Beikert F, Langenbruch A, Radtke M, Kornek T, Purwins S, Augustin M . Willingness to pay and quality of life in patients with atopic dermatitis. Arch Dermatol Res. 2013; 306(3):279-86. DOI: 10.1007/s00403-013-1402-1. View

5.
Wollina U . Is rosacea a systemic disease?. Clin Dermatol. 2019; 37(6):629-635. DOI: 10.1016/j.clindermatol.2019.07.032. View